Csenge Advisory Group Takes Position in Phibro Animal Health Co. (NASDAQ:PAHC)

Csenge Advisory Group bought a new position in Phibro Animal Health Co. (NASDAQ:PAHC) during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 20,687 shares of the company’s stock, valued at approximately $434,000. Csenge Advisory Group owned about 0.05% of Phibro Animal Health at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC increased its stake in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares during the last quarter. Barclays PLC grew its holdings in shares of Phibro Animal Health by 25.7% in the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after purchasing an additional 29,271 shares in the last quarter. Algert Global LLC increased its position in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock worth $1,606,000 after purchasing an additional 59,850 shares during the last quarter. FMR LLC raised its stake in Phibro Animal Health by 22.7% during the third quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after purchasing an additional 7,270 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its position in Phibro Animal Health by 3.1% during the third quarter. BNP Paribas Financial Markets now owns 24,336 shares of the company’s stock valued at $548,000 after purchasing an additional 729 shares during the last quarter. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

PAHC has been the topic of a number of research reports. Morgan Stanley boosted their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Barclays boosted their price objective on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com cut Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 6th. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat, Phibro Animal Health presently has an average rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Stock Performance

Phibro Animal Health stock opened at $25.82 on Wednesday. Phibro Animal Health Co. has a 1-year low of $11.90 and a 1-year high of $26.55. The company’s 50-day moving average is $22.17 and its 200 day moving average is $21.99. The firm has a market capitalization of $1.05 billion, a P/E ratio of 53.79, a price-to-earnings-growth ratio of 0.53 and a beta of 0.52. The company has a debt-to-equity ratio of 2.99, a current ratio of 3.20 and a quick ratio of 1.69.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Research analysts forecast that Phibro Animal Health Co. will post 1.94 EPS for the current year.

Phibro Animal Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.86%. The ex-dividend date is Wednesday, March 5th. Phibro Animal Health’s payout ratio is presently 100.00%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.